MARC Record from harvard_bibliographic_metadata

LEADER: 03752cam a2200517 a 4500
001 000403804-5
005 20110328155431.0
008 841226s1985 nyua b 10100 eng d
010 $a 84026547
020 $a0306419149
035 0 $aocm11599068
040 $aDNLM/DLC$cDLC$dOCL
050 00 $aRC692$b.I54 1983
050 4 $aQP751.A1$b.I64 1983
060 00 $aW1$bAD559 v.183 1985
060 10 $aQU 85$bI596 1983d
111 2 $aInternational Symposium on Drugs Affecting Lipid Metabolism$n(8th :$d1983 :$cPhiladelphia, Pa.)
245 10 $aDrugs affecting lipid metabolism VIII /$cedited by David Kritchevsky, William L. Holmes, and Rodolfo Paoletti.
260 0 $aNew York :$bPlenum Press,$cc1985.
300 $axiii, 502 p. :$bill. ;$c36 cm.
440 0 $aAdvances in experimental medicine and biology ;$vv. 183
500 $a"Proceedings of the Eighth International Symposium on Drugs Affecting Lipid Metabolism, held July 27-30, 1983, in Philadelphia, Pennsylvania"--T.p. verso.
504 $aIncludes bibliographies and indexes.
520 $aThe Proceedings of the Eight International Symposium on Drugs Affecting Lipid Metabolism (8th D.A.L.M.) is the subject of this volume. Since the first symposium in 1960, each successive meeting has broken new ground in the field of pharmacological control of lipid levels - offering new and stimulating insights and exposing the audience to the state of the art. The field has progressed sufficiently to permit discussion of the cellular biology of atherosclerosis. The opening session was devoted to pathology, macrophages, lipoproteins and their receptors and cholesterol ester metabolism. Because of the recent emergence of new apolipoprotein technology, a workshop devoted solely to apolipoprotein methodology was introduced followed by a plenary session devoted to their metabolism and structure.Another rapidly developing area of atherosclerosis research is non-invasive assessment of this condition. Accordingly, a session was devoted to new techniques for this research modality. The final plenary sessions were devoted to the roles of drugs and diet in atherosclerosis - cause, treatment and mechanisms of action. The meeting was summarized by Dr. O.J. Pollak, one of the "founding fathers" of this field. There were nine sessions of proffered. papers whose abstracts appear in this volume. In addition, special workshops (to be reported elsewhere) were devoted to several drugs including Oryzanol, Probucol and Etofibrate.
650 2 $aHypolipidemic Agents.
650 2 $aArteriosclerosis.
650 2 $aLipid Metabolism.
650 2 $aLipoproteins$xmetabolism.
650 2 $aMetabolism$xdrug effects.
655 2 $aCongresses.
650 0 $aAtherosclerosis$vCongresses.
650 0 $aBlood lipids$xMetabolism$xDisorders$vCongresses.
650 0 $aAntilipemic agents$vCongresses.
650 2 $aArteriosclerosis$vCongresses.
650 2 $aHypolipidemic Agents$vCongresses.
650 2 $aLipid Metabolism$vCongresses.
650 2 $aLipoproteins$xmetabolism$vCongresses.
650 2 $aMetabolism$xdrug effects$vCongresses.
700 1 $aKritchevsky, David,$d1920-2006.
700 1 $aHolmes, William L.,$d1918-
700 1 $aPaoletti, Rodolfo.
700 1 $aHolmes, William L.,$d1918-1989.
776 08 $iOnline version:$aInternational Symposium on Drugs Affecting Lipid Metabolism (8th : 1983 : Philadelphia, Pa.)$tDrugs affecting lipid metabolism VIII.$dNew York : Plenum Press, c1985$w(OCoLC)610147843
776 08 $iOnline version:$aInternational Symposium on Drugs Affecting Lipid Metabolism (8th : 1983 : Philadelphia, Pa.).$tDrugs affecting lipid metabolism VIII.$dNew York : Plenum Press, ©1985$w(OCoLC)610147843
988 $a20020608
906 $0OCLC